搜索临床试验以:琥珀酰化明胶
总计262个结果
-
Bukwang Pharmaceutical终止
-
Tibotec Pharmaceuticals, Ireland完全的
-
Vascular Solutions LLCKing Pharmaceuticals is now a wholly owned subsidiary of Pfizer完全的
-
Kimberly-Clark CorporationLawson Health Research Institute; Western University, Canada; Integrated Research Inc.完全的
-
ProgenaCare Global, LLCProfessional Education and Research Institute完全的
-
Bukwang Pharmaceutical终止
-
Turku University HospitalHelsinki University Central Hospital; Tampere University Hospital完全的
-
PhytoTech Therapeutics, Ltd.完全的
-
University of Paris 5 - Rene DescartesUniversity of Paris 13; University Paris 7 - Denis Diderot完全的
-
University Hospitals Cleveland Medical CenterEmory University招聘中
-
University of Auckland, New ZealandHealth Research Council, New Zealand完全的
-
Ain Shams University未知
-
Universidade Federal do Rio de JaneiroRio de Janeiro State Research Supporting Foundation (FAPERJ)完全的
-
Georgetown UniversityMedtronic - MITG终止Arteriovenous Access Grafts or Extra-anatomic and Infra-inguinal Grafts美国
-
Robin E. MillerNational Institute of General Medical Sciences (NIGMS); Thomas Jefferson University; Solutex GC...终止
-
Khon Kaen UniversityGeneral Drugs House Co.,LTD.; Ubon Ratchathani Cancer Hospital, Ubon Ratchathani完全的
-
University of Hamburg-EppendorfCharite University, Berlin, Germany; University of Leipzig; Universitätsklinikum Hamburg-Eppendorf 和其他合作者完全的
-
Daiichi Sankyo, Inc.Plexxikon终止V600 突变的 BRAF 不可切除黑色素瘤 | V600 突变的 BRAF 转移性黑色素瘤 | 先前未使用选择性 BRAF 抑制剂治疗的 III 期或 IV 期转移性黑色素瘤美国, 德国, 法国